Keywords: Stimuvax, Lung cancer vaccine, Merck Serono, Merck KGaA, FDA,

Merck Serono resumes Stimuvax trials in lung cancer vaccine as FDA lifts clinical hold

Article | 18 June 2010

Print This

Following a decision by the US Food and Drug Administration to lift a clinical hold imposed on trails of Merck ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in